Current Topics in Bioinformatics 2022: “AI and modelling techniques for fighting infectious diseases”
The fight against the Covid-19 epidemic has yet again shown how important AI techniques can be for biology and medicine. In this year’s edition of the Current Topics in Bioinformatics we thus want to focus on applications of bioinformatics, data science and modeling in infectious disease and, in particular, for understanding and fighting Covid-19. A wide range of techniques are currently contributing to this. On the molecular level, classical bioinformatics techniques like phylogeny construction and protein engineering are important. Dynamical and stochastic modeling are key to understanding the spread of the disease. Data science is needed to make sense from the plethora of indicators that are being collected, be it in the clinic or on a societal level. The workshop will highlight several aspects of this interplay of disciplines.
Program
Chair: Bertram Weiss, Bayer AG & Uwe Ohler, Max Delbrueck Center for Molecular Medicine (MDC)
2 pm
Welcome Address Steering Committee
Uwe Ohler, Max Delbrueck Center for Molecular Medicine (MDC)
Welcome Address Cluster HealthCapital
Jasmin Podufall, Berlin Partner fuer Wirtschaft und Technologie GmbH
2.15 pm
Keynote
The Data Donation Project - How wearable sensors can help in dealing with the COVID-19 crisis
Dirk Brockmann, Humboldt-Universität zu Berlin & Robert Koch Institut
2.45 pm
Building large virus phylogenies using serially sampled genomes
Prabhav Kalaghatgi, Max Planck Institute for Molecular Genetics
3.05 pm
SARS-CoV-2 infection dynamics revealed by wastewater sequencing analysis and deconvolution
Altuna Akalin, Max Delbrueck Center for Molecular Medicine (MDC)
3.30 pm
Coffee Break
4.20 pm
Data science for COVID research and in policy design
Max von Kleist, Robert Koch Institut
4.40 pm
'Synthetical Clinical Trial' to predict a COVID-19 treatment
Marco Schmidt, biotx.ai GmbH
5.00 pm
Control of COVID-19 outbreaks by predicting the effects of combining vaccination strategies with non pharmaceutical interventions
Edda Klipp, Humboldt-Universität zu Berlin
5.20 pm
Closing remarks
Martin Vingron, Max Planck Institute for Molecular Genetics
5.30 pm
Get Together